Skip to content

Clinical trials

Recruiting Phase 2 Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2 Status: Recruiting Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20181
20211
20232
20244
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Bastiaan Driehuys1
Centre Hospitalier Universitaire, Amiens1
Dana-Farber Cancer Institute1
Deciphera Pharmaceuticals, LLC1
Eli Lilly and Company1
Fundación GECP1
InSilico Medicine Hong Kong Limited1
Instituto Nacional de Cancerologia de Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases19
Carcinoma, Non-Small-Cell Lung4
Lung Diseases, Interstitial4
Lung Neoplasms4
Respiratory Tract Diseases4
Thoracic Neoplasms4
Carcinoma3
Fibrosis3
Respiratory Tract Neoplasms3
Asthma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.